We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKT icon
576
Rocket Pharmaceuticals
RCKT
$343M
$7.57K ﹤0.01%
2,321
-12
-0.5% -$38
CGEM icon
577
Cullinan Oncology
CGEM
$1.06B
$7.42K ﹤0.01%
1,251
-240
-16% -$1.76K
CHCT
578
Community Healthcare Trust
CHCT
$536M
$7.25K ﹤0.01%
474
-29
-6% -$454
ANNX icon
579
Annexon
ANNX
$796M
$7.21K ﹤0.01%
2,364
-365
-13% -$906
BFS
580
Saul Centers
BFS
$858M
$7.17K ﹤0.01%
225
-15
-6% -$495
ALT icon
581
Altimmune
ALT
$568M
$7.16K ﹤0.01%
1,899
+78
+4% +$301
SITC icon
582
SITE Centers
SITC
$236M
$7.15K ﹤0.01%
794
-51
-6% -$542
AMRN
583
Amarin Corp
AMRN
$297M
$7.11K ﹤0.01%
+434
New +$6.74K
TKNO icon
584
Alpha Teknova
TKNO
$266M
$7.09K ﹤0.01%
1,145
-220
-16% -$1.03K
AUTL
585
Autolus Therapeutics
AUTL
$389M
$6.95K ﹤0.01%
4,261
-852
-17% -$1.66K
REPL icon
586
Replimune Group
REPL
$455M
$6.9K ﹤0.01%
1,647
-323
-16% -$2.06K
XRN
587
Chiron Real Estate Inc
XRN
$535M
$6.74K ﹤0.01%
200
-29
-13% -$1.03K
EDIT icon
588
Editas Medicine
EDIT
$399M
$6.71K ﹤0.01%
1,935
-178
-8% -$497
LYEL icon
589
Lyell Immunopharma
LYEL
$318M
$6.71K ﹤0.01%
+413
New +$4.72K
SCPH
590
DELISTED
scPharmaceuticals
SCPH
$6.5K ﹤0.01%
1,147
-95
-8% -$486
ALEC icon
591
Alector
ALEC
$169M
$6.45K ﹤0.01%
2,178
-251
-10% -$553
NMRA icon
592
Neumora Therapeutics
NMRA
$306M
$6.34K ﹤0.01%
3,484
-399
-10% -$645
TECX
593
Tectonic Therapeutic
TECX
$536M
$6.32K ﹤0.01%
403
+26
+7% +$537
VNDA icon
594
Vanda Pharmaceuticals
VNDA
$304M
$6.25K ﹤0.01%
1,253
-240
-16% -$1.11K
ACIU icon
595
AC Immune
ACIU
$231M
$6.24K ﹤0.01%
2,160
-294
-12% -$664
OLP
596
One Liberty Properties
OLP
$542M
$6.19K ﹤0.01%
280
-28
-9% -$647
OMER icon
597
Omeros
OMER
$845M
$6K ﹤0.01%
1,464
-19
-1% -$75
CRCL
598
Circle Internet Group
CRCL
$15.3B
$5.97K ﹤0.01%
45
-15,216
-100% -$2.41M
LRMR icon
599
Larimar Therapeutics
LRMR
$377M
$5.95K ﹤0.01%
1,841
+258
+16% +$967
HUMA icon
600
Humacyte
HUMA
$168M
$5.93K ﹤0.01%
3,407
+112
+3% +$219
22 23
24
25 26

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.